Molecular diversity in the abdominal aortic aneurysm phenotype

Alpha1-antitrypsin deficiency and cardiovascular disease: questions and issues of a debated relation

Alpha1-antitrypsin (AAT) is one of the major inhibitors involved in protease/antiprotease homeostasis, and it is mainly produced by hepatocytes and pulmonary epithelial cells. Its deficiency, called alpha1-antitrypsin deficit (AATD), leads to severe hepatic and respiratory issues. Also, AAT is released into the bloodstream providing systemic anti-inflammatory effects. Apart from acting as an acute-phase anti-inflammatory protein, it can be a biomarker for monitoring disease evolution. A reduced or defective production leads to a loss of anti-inflammatory function, protease-antiprotease imbalance and cellular engorgement due to polymers deposition, with system-wide repercussions. This review aims to evaluate AATD condition in the major vessels of the head and neck, thoracic and abdominal districts. Also, a dedicated focus on autoimmune vascular diseases will be provided. A critical revision of the main literature findings starting from the 1980s until now has been performed. Studies conducted over the years have provided several contradictory pieces of evidence. Most authors acknowledge the protective and anti-inflammatory AAT role on the vascular endothelium. However, correlations between AATD and major arteries, cerebral and cardiovascular conditions, and autoimmune diseases remain unclear. Most studies recognize the role of AATD in vascular diseases but only as a cofactor inducing cellular and tissue structure impairments. However, this condition alone is not enough to determine new disease onset. Due to the opposing results reported over the years, there is still a considerable lack of knowledge on the role covered by AATD in vascular diseases. A renewed interest in this research field should be encouraged to grant new solid evidence and validate the putative role of AATD screening and replacement therapy as useful diagnostic and treatment tools.

The role of type III collagen in the development of familial abdominal aortic aneurysms

OBJECTIVES

to evaluate the prevalence of familiar abdominal aortic aneurysm (AAA) and the role of type III collagen deficiency.

METHODS

fifty-six consecutive patients coming for aneurysm repair were asked if one or more first-degree relatives had an AAA. During operation, a skin biopsy was taken from the patients for protein analysis to measure the type III collagen production in cultured fibroblasts.

RESULTS

a positive family history was found in 28.6% of the AAA patients. Six (10.7%) of the AAA patients had a type III collagen deficiency (mean 4.3% (S.D.+/-0.5)). In this group three men, mean age 65.3 years (S.D.+/-5.0), had a positive family history and a type III collagen deficiency. Segregation analysis with an intragenic marker in the type III collagen gene in a single family was in favour of linkage with the gene for type III procollagen (COL3A1) locus.

CONCLUSIONS

the high prevalence of familial AAA suggests a genetic aetiology. A small group of patients have a type III collagen deficiency. Linkage with the COL3A1 gene could not be proven or excluded in the families studied.

The lack of type III collagen in a patient with aneurysms and an aortic dissection

We analyzed 79 consecutive patients with aneurysms and found a patient who lacked type III collagen. Collagen was extracted from the skin, and the lack of type III collagen was determined by means of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Only 1 of the 79 patients was found to lack type III collagen. This patient was a 55-year-old man who had sustained an abdominal aortic aneurysm and aortic dissection. He did not show any of the typical clinical symptoms of Ehlers-Danlos syndrome type IV, such as hyperextensible skin and joints. He had none of the usual risk factors nor any clear family history of the syndrome. Furthermore, his collagen fibrils demonstrated a homogeneous appearance. This case may represent a new form of type III collagen deficiency.

Detection of type III collagen fragments in specimens of abdominal aortic aneurysms

The purpose of this study was to analyze the collagens in aortic aneurysm walls and to investigate the mechanism of the formation of calcified abdominal aortic aneurysms (AAAs). Collagens were extracted from human aneurysmal aortic walls obtained during surgery, and from human nonaneurysmal aortic walls obtained at autopsy, using pepsin-acetic acid digestion. Electrophoresis and immunoblotting were performed. Type III collagen was found to be reduced in the arteriosclerotic aneurysmal aortic walls. The alpha1 chain of type II collagen/alpha1 chain of type I collagen ratio was 0.35+/-0.11 in the aortic aneurysms and 0.68+/-0.11 in the nonaneurysmal aortic walls (P=0.0111). All the calcified aneurysms were associated with type III collagen fragments having molecular mass of approximately 70 kDa and 30 kDa as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Thus, we concluded that AAAs with calcification may be caused by an abnormal degradation of type III collagen.

Abdominal aortic aneurysm: a general defect in the vasculature with focal manifestations in the abdominal aorta?

PURPOSE

It has been suggested that abdominal aortic aneurysms (AAA) develop as a result of an alteration in the systemic connective tissue metabolism. This might change wall mechanics and diameter, not only in the AAA but also in the rest of the vascular system. This hypothesis was tested by studying the mechanical properties of AAAs as well as the common carotid artery (CCA) in the same patient population.

METHODS

AAA and carotid artery stiffness (beta) was studied in 121 individuals (101 men, 20 women) who were admitted for elective repair of AAA. Stiffness (beta) was calculated from diameter and pulsatile diameter change determined noninvasively from an ultrasonic echo-tracking system and blood pressure obtained by the auscultatory method. The results were compared with those of healthy individuals of corresponding age and gender published elsewhere.

RESULTS

The stiffness of the AAA was increased in both men and women (p = 0.0001). The increase was more pronounced in women compared with men (p = 0.0003) to a mean of 435% and 189% of the normal predicted values, respectively. In the CCA, the stiffness was increased in men (p = 0.027) and in women (p = 0.0001) to a mean of 131% and 149% of the normal predicted values, respectively. A significant correlation between stiffness in the aneurysm and in the carotid artery was seen (p = 0.0031). The carotid diameter was unchanged in men (p = 0.924) and in women (p = 0.070) if adjusted for the difference in blood pressure between the individuals with AAAs and control subjects. There was no correlation between stiffness and diameter of the aneurysm in men (r = 0.16, p = 0.119) nor in women (r = 0.12, p = 0.598).

CONCLUSIONS

This investigation demonstrated altered mechanical properties of the aneurysmal wall as well as in the CCA in individuals with AAAs. The normal age- and gender-related differences seen in the healthy aorta and CCA vanished. The results suggest that AAA is a generalized process of the vasculature with focal manifestation in the abdominal aorta.